Analyst ratings and price targets can significantly influence a company's stock price. In this case, UBS, a reputable financial institution, has initiated coverage on Aptiv with a Buy rating and a price target of $143. This suggests that UBS sees potential in Aptiv and expects its stock price to rise, which could lead to increased investor interest and a potential increase in the stock price.